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Abstract
Background: Low birth weight (LBW) has been associated with an increased risk of cardiovascular disease (CVD). A
previous study, however, found higher risk of atrial fibrillation (AF) in individuals with higher birth weight (BW). To
further understand this apparent paradox, we examined the relationship between AF and BW in the Atherosclerosis
Risk in Communities (ARIC) cohort.
Methods: The analysis included 10,132 individuals free of AF at baseline (1996–1998), who provided BW information,
were not born premature, and were not a twin. Self-reported BW was categorized as low (<2.5 kg), medium (2.5-4 kg),
and high (>4.0 kg). AF incidence was ascertained from hospital discharge codes and death certificates. We used
multivariable Cox proportional hazard models to determine the hazard ratios (HR) and 95% confidence intervals
(CI) of AF across BW groups.
Results: During an average follow-up of 10.3 years, we identified 882 incident AF cases. LBW was associated with
higher risk of AF. Compared to individuals in the medium BW category, the HR (95% CI) of AF was 1.33 (0.99, 1.78) for
LBW and 1.00 (0.81, 1.24) for high BW after adjusting for sociodemographic variables (p for trend = 0.29). Additional
adjustment for CVD risk factors did not attenuate the associations (HR 1.42, 95% CI 1.06, 1.90 for LBW and HR 0.86,
95% CI 0.69-1.07 for high BW, compared to medium BW, p for trend = 0.01).
Conclusion: LBW was associated with a higher risk of AF. This association was independent of known predictors
of AF and is consistent with that observed for other cardiovascular diseases.
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Background
Atrial fibrillation (AF) is the most common sustained
cardiac arrhythmia encountered in clinical practice [1].
AF affects more than 2 million Americans [2], increases
the risk of heart failure, stroke, myocardial infarction,
and overall mortality [3-6], and contributes significantly
to healthcare costs [7].
The developmental origins of health and adult disease
postulates that in response to a suboptimal intrauterine
environment the fetus employs numerous survival
mechanisms, including growth restriction, at the expense
of an increased susceptibility to a wide range of chronic
disease in adulthood. Birth weight (BW) is frequently
used as a proxy for impaired fetal growth in lieu of more
precise data on fetal growth trajectory. Numerous stud-
ies have suggested that low BW (LBW) is related to an
increased propensity towards the development of cardio-
vascular [8,9], metabolic, and endocrine abnormalities in
later life [10].
Few data exist regarding the potential relationship be-
tween BW and subsequent risk of AF. LBW has been as-
sociated with the increased risk of development of
hypertension later in life [11], an established risk factor
of AF. However, the only published study that explored
the impact of BW on risk of AF in adulthood, based on
the Women’s Health Study, found that higher BW was
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associated with an increased risk of AF, rather than de-
creased risk as might be expected given the fetal origins
hypothesis [12].
The incidence of AF is significantly lower in African
Americans compared to whites despite the increased
prevalence of risk factors of AF in African Americans,
such as hypertension or obesity [13-15]. In addition, the
prevalence of LBW is higher among African Americans
than whites [16]. Assessing whether black-white differ-
ences in BW could explain the paradoxical racial dispar-
ity in AF risk merits attention.
Therefore, the aim of this study was to assess the rela-
tionship between BW and AF risk, including assessment
of effect modification by gender and race, using data




The ARIC study is an ongoing prospective cohort in
four communities in the US: Forsyth County, North
Carolina; Washington County, Maryland; Minneapolis
suburbs, Minnesota; and Jackson, Mississippi [17]. Par-
ticipants in the cohort were randomly selected from a
defined population of age 45–64. At baseline (1987–1989),
15,792 participants were recruited and received medical
examinations. Three follow-up examinations were per-
formed every three years, and a fourth follow-up exam
was conducted in 2011–2013. In addition, study par-
ticipants receive annual phone follow-up calls to get
updates on health and vital status. The ARIC study is per-
formed in accordance with the Declaration of Helsinki
and has been approved by Institutional Review Boards
(IRB) at all participating institutions: University of North
Carolina at Chapel Hill IRB, Johns Hopkins University
IRB, University of Mississippi Medical Center IRB, and
University of Minnesota IRB. Study participants provided
written informed consent at all study visits.
For this study we included only whites and African
Americans who participated in ARIC visit 4 (1996–98),
when BW was assessed. Individuals with missing in-
formation on BW or any other covariate of interest,
reported cases of prematurity, twins, and individuals
with prevalent AF at visit 4 were excluded. Table 1
shows the exclusion criteria with the resultant 10,132
observations used in the analysis.
Study measures
Birth weight
At the visit 4 exam (1996–98), participants were asked to
recall their exact BW in pounds and ounces, and those who
could not recall their exact BW were asked to categorize
it into one of three categories: low (<5.5 lbs/<2.5 kg.),
medium (5.5–9.0 lbs./2.5-4.0 kg) or high (>9.0 lbs./>4.0 kg).
Actual reported weights were grouped using these
same categories. This three-level ordinal variable was
used in all analyses. Participants reporting exact BW
were more likely to be white and female [18]. In the
ARIC cohort, categories of self-reported exact BW
followed a similar distribution to BW in the general US
population [18]. Studies in other populations suggest
that self-reported birth weight has moderate to good
validity [19].
AF ascertainment
Data on AF was obtained from 12-lead ECGs performed
in study exams, from ICD-9 codes from hospitalization
discharges (427.31, 427.32) or from death certificates if
AF was listed as any cause of death (ICD-9 427.3 or
ICD-10 I48) [15]. More than 90% of AF cases were iden-
tified from hospital discharges. In the present analysis,
we considered incident AF as any first occurrence of AF
between visit 4 and December 31, 2008; after visit 4, all
AF cases were identified from hospital discharge codes
and death certificates.
Other variables
Other covariates were defined based on information col-
lected at visit 4 (with the exception of education level
and income, which were collected at visit 1). Question-
naires provided information on age, gender, educational
level, income, cigarette smoking, alcohol intake, and use
of hypertensive medication. Blood pressure, height and
weight were measured at the study visit. Body mass
index (BMI) was computed as weight in kilograms divided
by height in meters squared. Diabetes was defined as
fasting serum glucose ≥126 mg/dL, use of anti-diabetic
medication, non-fasting serum glucose ≥200 mg/dL, or
a self-reported diagnosis of diabetes. Prevalent MI and
heart failure were defined as previously described [20,21].
Statistical analysis
The causal model guiding our selection of covariates for
multivariable analysis is presented in Figure 1. A brief
Table 1 Number of excluded participants according to




Initial cohort in 1987-89 15,792
Attended visit 4 (1996–98) 4,136 11,656
Prevalent AF at visit 4 298 11,358
Low or bad quality ECGs at baseline 175 11,183
Race other than white or African American 67 11,116
Missing Covariates 151 10,965
Twin gestation or premature infant 490 10,475
Missing BW 343 10,132
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justification for this model follows. Our main question
of interest is whether intrauterine growth retardation,
assessed with BW as a proxy, leads to AF. Based on
existing literature, this association could be mediated by
an increase in the risk of cardiovascular risk factors
(diabetes, hypertension, obesity, etc.) and cardiovascular
disease [8-10], which are well-established risk factors
for AF [22]. Male gender and white race are associated
with higher birth weight in our sample (Table 1) and are
also associated with AF risk [15], therefore being con-
sidered confounders. Maternal socioeconomic status
(SES), through a range of mechanisms, is associated
with intrauterine growth retardation and, through its
impact on an individual’s SES, can affect the future risk
of AF. Since we do not have information on maternal
SES, we used individual SES as a proxy, including edu-
cation, income, and study site as potential confounders.
Finally, we considered all other cardiovascular risk fac-
tors as variables possibly in the causal pathway between
intrauterine growth retardation/BW and AF risk. Esti-
mation of the total effect of birth weight on AF should
not adjust for those variables; however, a model adjust-
ing for those variables could be used to test whether any
association between BW and AF is mediated through
changes in cardiovascular risk factors or through other,
not described, pathways (represented by the red dashed
line in Figure 1), provided that some assumptions are
met. These assumption include the absence of uncon-
trolled confounding between the exposure and the out-
come, absence of uncontrolled confounding between
the mediator and the outcome, and no effect measure
modification between the exposure and the mediator in
their association with the outcome [23].
In all analyses, we categorized BW into low (<2.5 kg),
medium (2.5 - 4.0 kg), and high (>4.0 kg). The associ-
ation between categories of BW and incidence of AF
was estimated using hazard ratios (HR) and 95% confi-
dence intervals (CI) obtained from Cox proportional
hazards models, using medium BW as the reference
category. An initial analysis was conducted on the entire
sample, followed by race and gender-stratified analyses.
Time of follow-up was defined as number of days be-
tween visit 4 and incident AF, death, lost during follow-
up, or December 31, 2008, whichever occurred earlier.
We conducted initial analysis adjusted for potential
confounders: Model 1 adjusted for age, race and gender.
Model 2 adjusted additionally for socioeconomic factors
(income and education) and study center. Variables in
models 1 and 2 can be considered confounders since
they may be determinants of BW and are also risk fac-
tors for AF. Finally, we ran an additional model 3 that
included cardiovascular risk factors as potential me-
diators, i.e. in the causal pathway, of the association
between BW and AF risk (diabetes, systolic blood pres-
sure (SBP), hypertension medications, smoking, height,
BMI, prevalent myocardial infarction, and heart failure).
Based on our assumptions about causal relationships,
this model specifically tests whether a direct effect of
BW on AF risk exists independently of these mediators
(Figure 1). Assumptions for this test include: (1) no
uncontrolled confounding between the exposure (BW)
and the outcome (AF), (2) no uncontrolled confounding
between the mediators (cardiovascular risk factors) and
the outcome (AF), and (3) no effect measure modifi-
cation between the exposure and the mediators [23].
We considered the first two assumptions to hold be-
cause of our adjustment for predictors of BW, AF, and
cardiovascular risk factors. We did not find significant
effect measure modification between BW and prevalence
of cardiovascular risk factors regarding the association
with AF (data not shown), considering the third assump-
tion to hold.
Figure 1 Causal model for the association of birth weight, as a proxy for intrauterine growth restriction, with the incidence of atrial
fibrillation. The red-dashed line represents a hypothetical direct effect of intrauterine growth retardation on atrial fibrillation incidence not
mediated through known cardiovascular risk factors. CVD: Cardiovascular disease. SES: Socioeconomic status.
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Pre-specified analyses testing for interactions by race
and gender were performed including multiplicative terms
in the models and conducting race- and gender-stratified
analyses. Test for trends were conducted by including BW
category in the models as an ordinal variable. We con-
ducted two sensitivity analyses, first including only those
participants who reported their exact BW in pounds and
ounces, and second starting follow-up at ARIC visit 1,
instead of visit 4, and including all incident cases from
visit 1. All analyses were conducted with SAS version 9.2
(SAS Institute Inc., Cary, NC).
Results
Baseline characteristics
At visit 4, the mean age of the 10,132 eligible individuals
was 62.7 years (standard deviation, 5.7). Of these, 449
(4%) reported LBW, 1,086 (11%) reported high BW,
while the remaining 8,597 (85%) reported medium BW.
Table 2 shows characteristics of the study sample by
categories of BW. Approximately 44% of the eligible par-
ticipants were men. Women and African Americans
were more likely to be in the LBW category (P < 0.001).
Association between BW category and incident AF
During an average 10.3 years of follow-up, we identified
882 incident AF cases. The crude incidence rate of AF in
the study population was 8.4 events per 1000 person
years. Incidence rates across BW categories were: 10.5
events per 1000 person-years for those with LBW, 8.3
events per 1000 person-years for the medium BW cat-
egory, and 8.8 events per 1000 person-years for the high
BW category (Table 3).
In multivariable models, LBW was associated with a
higher risk of AF compared to medium BW (Table 3).
After adjusting for socio-demographic variables (Model 2),
individuals in the LBW category had an approximate 33%
increase in AF risk compared to those with medium BW:
HR 1.33, 95% CI 0.99, 1.78. High BW, compared to
medium BW, was not associated with the risk of AF
(HR 1.00, 95% CI 0.81, 1.24). The association remained
after controlling for potential mediators (Model 3), sug-
gesting the presence of alternative pathways between
BW and AF risk. Results remained essentially unchanged
when we started the follow-up at visit 1, including all inci-
dent cases occurring afterwards (1131 AF cases; Model 2:
HR 1.34, 95% CI 1.03, 1.74 for LBW; HR 1.04, 95% CI
0.86, 1.25 for high BW, compared to medium BW).
An analysis restricted to the 4810 ARIC participants
(including 412 AF cases) who reported their exact BW
in pounds and ounces provided similar estimates of
association. The HRs (95% CI) for low and high BW
compared to medium BW were respectively 1.23 (0.85,
1.79) and 0.91 (0.71, 1.16) in models adjusted for socio-
demographic variables, and 1.32 (0.91, 1.93) and 0.81
(0.63, 1.04) after additional adjustment for cardiovas-
cular disease risk factors.
Association between BW and incident AF by race
The interaction term race*BW was not statistically signifi-
cant (p-value = 0.28). Nonetheless, we conducted race-
stratified analysis, as pre-specified in our hypothesis.
Table 4 shows the association between BW and AF by
race. Among whites, LBW was associated with higher
risk of AF, with an increase of 35% in AF risk in models
Table 2 Baseline characteristics of study participants by self-reported birth weight categories, ARIC study, 1996-2008
Birth weight categories
Low Medium High P value*
N (%) 449 (4%) 8,597 (85%) 1,086 (11%)
Age, years (mean ± SD) 62.7 ± 5.6 62.7 ± 5.7 62.8 ± 5.6 0.89
Male, % 22.1 42.6 59.1 <0.001
African American, % 26.7 21.1 16.3 <0.001
Less than high school degree, % 25.2 18.3 15.8 <0.001
BMI, kg/m2 (mean ± SD) 28.5 ± 6.0 28.7 ± 5.5 29.4 ± 5.9 0.001
Height, cm (mean ± SD) 162.6 ± 8.6 168.2 ± 9.0 172.5 ± 9.1 <0.001
Diabetes, % 19.8 15.8 14.6 0.04
SBP, mmHg (mean ± SD) 129.3 ± 19.1 127.4 ± 18.9 125.4 ± 18.0 <0.001
Hypertensive medication use, % 47.4 42.4 39.2 0.01
Current smoker, % 17.8 14.2 17.3 <0.001
Prevalent heart failure, % 1.3 1.3 2.2 0.06
Prevalent myocardial infarction, % 3.3 2.7 2.9 0.69
Incident atrial fibrillation, % 10.9 8.6 9.2 0.21
BMI: Body mass index; SBP: systolic blood pressure.
*P value based on chi square test for categorical variables and analysis of variance for continuous variables.
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adjusted for sociodemographic characteristics, com-
pared to LBW. The association was less apparent among
African Americans, with individuals in the medium
BW category showing the lowest risk of AF. African-
American race was associated with lower risk of AF
compared to white race after adjusting for age, gender,
and birth weight category (HR 0.84, 95% CI 0.70-1.00).
Association between BW category and incident AF by
gender
As with race, no significant interaction was observed be-
tween gender and BW (p-value = 0.21). The pre-specified
analysis showing the association between BW and AF risk
by gender is presented in Table 5. LBW showed a strong
association with AF risk in men, while in women, no clear
evidence of an association between BW and AF risk was
present.
Discussion
Our study showed an association between BW and inci-
dent AF, with higher risk of AF among individuals with
LBW, compared to medium BW. These results are
similar to what has been generally observed for the
relationship of BW with other cardiovascular diseases
[8,9]. The association was more evident in men and
whites; BW was a weaker risk factor for AF in women
and African Americans. Our results are consistent with
the fetal origin hypothesis of coronary heart disease
Table 3 Hazard ratios and 95% confidence intervals of atrial fibrillation by birth weight category, ARIC study, 1996-
2008
Birth weight categories
Low Medium High P for trend
AF events, N 49 735 98
Person-years 4,662 88,982 11,095
Incidence Rate* (95% CI) 10.5 (7.9-13.8) 8.3 (7.7-8.9) 8.8 (7.2-10.7)
Model 1 1.37 (1.03, 1.84) 1 (ref.) 1.00 (0.81, 1.23) 0.21
Model 2 1.33 (0.99, 1.78) 1 (ref.) 1.00 (0.81, 1.24) 0.29
Model 3 1.42 (1.06, 1.90) 1 (ref.) 0.86 (0.69, 1.07) 0.01
*Incidence rate per 1000 person years.
Model 1: Cox proportional hazards model adjusted for age, race and gender.
Model 2: As model 1, additionally adjusted for study center, income, and education.
Model 3: As model 2, additionally adjusted for diabetes, systolic blood pressure, hypertension medications, smoking, height, body mass index, prevalent.
myocardial infarction and heart failure.
Table 4 Hazard ratios and 95% confidence intervals of atrial fibrillation by birth weight category, stratified by race,
ARIC study, 1996-2008
Birth weight categories
Whites (N = 8,022, AF events = 743) Low Medium High P for trend
AF events, N 38 624 81
Person-years 3,471 70,183 9,304
Incidence Rate* (95% CI) 10.9 (7.9-14.9) 8.9 (8.2-9.6) 8.7 (7.0-10.8)
Model 1 1.35 (0.97, 1.88) 1 (ref.) 0.92 (0.73, 1.16) 0.10
Model 2 1.30 (0.94, 1.81) 1 (ref.) 0.92 (0.73, 1.16) 0.13
Model 3 1.38 (0.99, 1.92) 1 (ref.) 0.79 (0.63, 1.00) 0.007
African Americans (N = 2,110, AF events = 139) Low Medium High
AF events, N 11 111 17
Person-years 1,191 18,798 1,791
Incidence Rate* (95% CI) 9.2 (4.9-16.0) 5.9 (4.9-7.1) 9.5 (5.7-14.9)
Model 1 1.51 (0.81, 2.81) 1 (ref.) 1.64 (0.98, 2.74) 0.55
Model 2 1.49 (0.80, 2.78) 1 (ref.) 1.75 (1.04, 2.93) 0.44
Model 3 1.60 (0.86, 2.99) 1 (ref.) 1.37 (0.80, 2.34) 0.97
*Incidence rate per 1000 person years.
Model 1: Cox proportional hazards model adjusted for age and gender.
Model 2: As model 1, additionally adjusted for study center, income, and education.
Model 3: As model 2, additionally adjusted for diabetes, systolic blood pressure, hypertension medications, smoking, height, body mass index, prevalent.
myocardial infarction and heart failure.
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and other developmental theories that associate cardiovas-
cular disease in adulthood with undernutrition in utero
[24]. Adverse prenatal factors that may have caused intra-
uterine growth restriction could also lead to metabolic
and organ changes that can predispose affected individuals
to chronic disease in adulthood. This suggests that LBW,
an indication of possible intrauterine growth restriction,
may be a risk factor for developing AF later in life.
LBW has been associated with a higher risk for hyper-
tension and diabetes [10,11]. Reduced fetal growth may
result in changes in fetal blood flow or hormonal varia-
tions, which can lead to abnormal development of vari-
ous organs involved in blood pressure control including
the kidneys, autonomic nervous system, endocrine glands,
and cardiac vasculature. In the kidney, these changes
would result in fewer nephrons, potentially leading to poor
salt regulation and hypertension [25]. In the pancreas, they
could result in a reduced beta cell mass and poor regula-
tion of glucose later in life predisposing one to diabetes. It
has been suggested that the higher prevalence of diabetes
in individuals with LBW could reflect a selective survival
of LBW infants genetically susceptible to diabetes [26].
Studies have shown that obesity, diabetes and hyperten-
sion are strong risk factors for developing AF [27,28].
Therefore, the increased risk of AF associated with LBW
could be mediated through a higher risk of cardiometa-
bolic risk factors. In our analysis, however, associations
remained after adjustment for cardiovascular risk factors,
which would suggest that other variables mediate this
association.
Results from the ARIC Study contradict those previ-
ously reported in the Women’s Health Study, which
found a higher risk of AF among women with higher
BW [12]. Some important differences exist between both
studies, though. The Women’s Health Study included
only women, mostly white, all of them health profes-
sionals. The ARIC study, in contrast, included a biracial
population of both genders, with a more diverse educa-
tional background. Other differences between studies in-
clude the potential different quality of BW information
(possibly higher in the Women’s Health Study, since par-
ticipants were all female and more educated on average),
the method for ascertainment of AF, and the availability
of potential confounders. Future research in other popu-
lation should try to clarify this apparent inconsistency.
In race and gender-stratified models, we found that
the association of LBW with the risk of incident AF was
stronger in men and whites than in women and African
Americans, although these differences were not statisti-
cally significant. Possible explanations for the gender
and race disparity are the differential distribution of BW
and different degree of misclassification in BW informa-
tion across different demographic groups. Of note, the
previously reported lower AF risk in African Americans
vs whites [15] in the ARIC cohort remained after adjust-
ment for birth weight categories.
Study limitations and strengths
Several important limitations exist regarding the infor-
mation on BW. First, about 50% of the participants
Table 5 Hazard ratio and 95% confidence intervals of atrial fibrillation by birth weight category, stratified by gender,
ARIC study, 1996-2008
Birth weight categories
Men (N = 4,403, AF events = 453) Low Medium High P for trend
AF events, N 19 374 60
Person-years 982 36,754 6,410
Incidence Rate* (95% CI) 19.4 (12.0-29.6) 10.2 (9.2-11.2) 9.4 (7.2-12.0)
Model 1 1.92 (1.21, 3.04) 1 (ref.) 0.92 (0.70, 1.20) 0.07
Model 2 1.91 (1.20, 3.03) 1 (ref.) 0.92 (0.70, 1.20) 0.07
Model 3 1.91 (1.20, 3.04) 1 (ref.) 0.80 (0.61, 1.06) 0.009
Women (N = 5,729, AF events = 429) Low Medium High
AF events, N 30 361 38
Person-years 3,680 52,227 4,685
Incidence Rate* (95% CI) 8.2 (5.6-11.5) 6.9 (6.2-7.7) 8.1 (5.8-11.0)
Model 1 1.17 (0.80, 1.69) 1 (ref.) 1.16 (0.83, 1.62) 0.92
Model 2 1.13 (0.78, 1.64) 1 (ref.) 1.17 (0.83, 1.63) 0.80
Model 3 1.23 (0.84, 1.79) 1 (ref.) 0.97 (0.67, 1.36) 0.51
*Incidence rate per 1000 person years.
Model 1: Cox proportional hazards model adjusted for age and gender.
Model 2: As model 1, additionally adjusted for study center, income, and education.
Model 3: As model 2, additionally adjusted for diabetes, systolic blood pressure, hypertension medications, smoking, height, body mass index, prevalent.
myocardial infarction and heart failure.
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could not recall their exact BW and, thus, only BW cat-
egories could be used (low, medium, high BW). Second,
the overall prevalence of LBW in our sample (4%) is
lower than expected, suggesting underreporting of LBW
[18]. In an analysis including only those with self-
reported exact BW, which possibly provided more valid
BW information [18], results remained unchanged.
Third, the absence of gestational age information also
adds to misclassification errors; infants experiencing
normal fetal growth but born somewhat earlier are
combined with those that are small for gestational age,
which suggests intrauterine growth restriction. How-
ever, participants were asked if they were born prema-
ture, and excluded if the answer was affirmative, thus
decreasing the magnitude of this potential misclassifica-
tion. Similarly, the relatively low number of AF events
in the LBW category may compromise the robustness
of our results. Another important limitation is that AF
was mostly ascertained from hospital discharge codes,
which could lead to missing AF events identified in out-
patient settings only. We and others have showed previ-
ously, however, that this method has adequate validity
for epidemiologic studies of AF [15,29]. Finally, BW in-
formation was not collected until study participants
were in late midlife (average age at baseline 63), which
might lead to selection bias if study dropout status or
non-participation was associated with BW and AF or
AF risk factors. However, we adjusted our analysis for
known established risk factors for AF thus reducing this
bias [30].
Major strengths of this study include the large sample
size, the inclusion of both whites and African Ameri-
cans, extended follow-up, and availability of information
on confounding variables (socioeconomic status) and
mediators (anthropometry, cardiovascular risk factors).
Conclusion
In conclusion, in this biracial cohort study, LBW was as-
sociated with an increased risk of incident AF. This asso-
ciation was independent of known predictors of AF such
as hypertension, BMI and height. This association may
be stronger in men and whites. Given the differences in
results from the ARIC Study and the Women’s Health
Study, additional research in other diverse populations
should be conducted to clarify the relationship between
birth weight and AF risk.
The authors thank the staff and participants of the
ARIC study for their important contributions.
Competing interests
The authors have no conflict of interest to disclose related to the present
manuscript.
Authors’ contributions
The study was designed by SOW, EWD, KMR, and AA. Data on AF were
collected by EZS and AA. SOW and FLL analyzed the data. SOW and AA
wrote the first draft of the manuscript. All authors participated in data
interpretation, discussion and preparation of the final manuscript, and read
and approved the final manuscript.
Acknowledgments
The Atherosclerosis Risk in Communities Study is carried out as a
collaborative study supported by National Heart, Lung, and Blood Institute
contracts (HHSN268201100005C, HHSN268201100006C,
HHSN268201100007C, HHSN268201100008C, HHSN268201100009C,
HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). This
study was additionally supported by grants RC1-HL099452 from the National
Heart, Lung, and Blood Institute and 09SDG2280087 from the American
Heart Association.
Author details
1Division of Epidemiology and Community Health, School of Public Health,
University of Minnesota, 1300 S 2nd St, Minneapolis, MN, USA.
2Epidemiological Cardiology Research Center (EPICARE), Wake Forest School
of Medicine, Winston-Salem, NC, USA. 3School of Population Health,
University of Queensland, Brisbane, Queensland, Australia. 4Department of
Epidemiology, University of North Carolina, Chapel Hill, NC, USA, and Social
and Scientific Systems, Inc, Durham, NC, USA.
Received: 21 February 2014 Accepted: 23 May 2014
Published: 26 May 2014
References
1. Magnani JW, Rienstra M, Lin H, Sinner MF, Lubitz SA, McManus DD, Dupuis J,
Ellinor PT, Benjamin EJ: Atrial fibrillation: current knowledge and future
directions in epidemiology and genomics. Circulation 2011, 124:1982–1993.
2. Go AS, Hylek EM, Phillips KA, Chang YC, Henault LE, Selby JV, Singer DE:
Prevalence of diagnosed atrial fibrillation in adults. National implications
for rhythm management and stroke prevention: the anticoagulation and
risk factors in atrial fibrillation (ATRIA) study. JAMA 2001, 285:2370–2375.
3. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk
factor for stroke: the Framingham study. Stroke 1991, 22:983–988.
4. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D:
Impact of atrial fibrillation on the risk of death: the Framingham heart
study. Circulation 1998, 98:946–952.
5. Conen D, Chae CU, Glynn RJ, Tedrow UB, Everett BM, Buring JE, Albert CM:
Risk of death and cardiovascular events in initially healthy women with
new-onset atrial fibrillation. JAMA 2011, 305:2080–2087.
6. Soliman EZ, Safford MM, Muntner P, Khodneva Y, Dawood FZ, Zakai NA,
Thacker EL, Judd S, Howard VJ, Howard G, Herrington DM, Cushman M:
Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med
2014, 174:107–114.
7. Kim MH, Johnston SS, Chu B-C, Dalal MR, Schulman KL: Estimation of total
incremental health care costs in patients with atrial fibrillation in the
United States. Circ Cardiovasc Qual Outcomes 2011, 4:313–320.
8. Huxley R, Owen CG, Whincup PH, Cook DG, Rich-Edwards J, Smith GD,
Collins R: Is birth weight a risk factor for ischemic heart disease in later
life? Am J Clin Nutr 2007, 85:1244–1250.
9. Eriksson JG, Forsén T, Tuomilehto J, Osmond C, Barker DJP: Early growth,
adult income, and risk of stroke. Stroke 2000, 31:869–874.
10. Whincup PH, Kaye SJ, Owen CG, Huxley RR, Cook DG, Anazawa S, Barrett-
Connor E, Bhargava SK, Birgisdottir BE, Carlsson S, de Rooij SR, Dyck RF,
Eriksson JG, Falkner B, Fall C, Forsén T, Grill V, Gudnason V, Hulman S,
Hypponen E, Jeffreys M, Lawlor DA, Leon DA, Minami J, Mishra G, Osmond C,
Power C, Rich-Edwards JW, Roseboom TJ, Sachdev HS, et al: Birth weight and
risk of type 2 diabetes: a systematic review. JAMA 2008, 300:2886–2897.
11. Huxley RR, Shiell AW, Law CM: The role of size at birth and postnatal
catch-up growth in determining systolic blood pressure: a systematic
review of the literature. J Hypertens 2000, 18:815–831.
12. Conen D, Tedrow UB, Cook NR, Buring JE, Albert CM: Birth weight is a
significant risk factor for incident atrial fibrillation. Circulation 2010,
122:764–770.
13. Soliman EZ, Alonso A, Goff DC Jr: Atrial fibrillation and ethnicity: the
known, the unknown and the paradox. Future Cardiol 2009, 5:547–556.
14. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R,
Furberg C, Rautaharju PM: Incidence of and risk factors for atrial fibrillation in
older adults. Circulation 1997, 96:2455–2461.
Lawani et al. BMC Cardiovascular Disorders 2014, 14:69 Page 7 of 8
http://www.biomedcentral.com/1471-2261/14/69
15. Alonso A, Agarwal SK, Soliman EZ, Ambrose M, Chamberlain AM, Prineas RJ,
Folsom AR: Incidence of atrial fibrillation in whites and African-Americans:
the atherosclerosis risk in communities (ARIC) study. Am Heart J 2009,
158:111–117.
16. David RJ, Collins JW: Differing birth weight among infants of U.S.-born
blacks, African-born blacks, and U.S.-born whites. N Engl J Med 1997,
337:1209–1214.
17. The ARIC Investigators: The atherosclerosis risk in communities (ARIC)
study: design and objectives. Am J Epidemiol 1989, 129:687–702.
18. Rose KM, Tilling K, Folsom AR, Coresh J: Evaluation of self-reported birth
weight in older adults. Circulation 2004, 7:E127–E127.
19. Tehranifar P, Liao Y, Flom JD, Terry MB: Validity of self-reported birth
weight by adult women: sociodemographic influences and implications
for life-course studies. Am J Epidemiol 2009, 170:910–917.
20. White AD, Folsom AR, Chambless LE, Sharret AR, Yang K, Conwill D,
Higgins M, Williams OD, Tyroler HA, The ARIC Investigators: Community
surveillance of coronary heart disease in the atherosclerosis risk in
communities (ARIC) study: methods and initial two years' experience.
J Clin Epidemiol 1996, 49:223–233.
21. Loehr LR, Rosamond WD, Chang PP, Folsom AR, Chambless LE: Heart failure
incidence and survival (from the atherosclerosis risk in communities study).
Am J Cardiol 2008, 101:1016–1022.
22. Alonso A, Krijthe BP, Aspelund T, Stepas KA, Pencina MJ, Moser CB, Sinner
MF, Sotoodehnia N, Fontes JD, Janssens ACJW, Kronmal RA, Magnani JW,
Witteman JC, Chamberlain AM, Lubitz SA, Schnabel RB, Agarwal SK,
McManus DD, Ellinor PT, Larson MG, Burke GL, Launer LJ, Hofman A, Levy D,
Gottdiener JS, KÃ¤Ã¤b S, Couper D, Harris TB, Soliman EZ, Stricker BHC, et al:
Simple risk model predicts incidence of atrial fibrillation in a racially and
geographically diverse population: the CHARGE-AF Consortium. J Am
Heart Assoc 2013, 2:e000102.
23. Kaufman JS, MacLehose RF, Kaufman S: A further critique of the analytic
strategy of adjusting for covariates to identify biologic mediation.
Epidemiol Perspect Innov 2004, 1:4.
24. Barker DJP: The developmental origins of adult disease. J Am Coll Nutr
2004, 23:588S–595S.
25. Brenner BM, Chertow GM: Congenital oligonephropathy and the etiology
of adult hypertension and progressive renal injury. Am J Kidney Dis 1994,
23:171–175.
26. Hales CN, Barker DJP: The thrifty phenotype hypothesis. Br Med Bull 2001,
60:5–20.
27. Magnani JW, Hylek EM, Apovian CM: Obesity begets atrial fibrillation: a
contemporary summary. Circulation 2013, 138:401–405.
28. Huxley RR, Lopez FL, Folsom AR, Agarwal SK, Loehr LR, Soliman EZ,
Maclehose R, Konety S, Alonso A: Absolute and attributable risks of atrial
fibrillation in relation to optimal and borderline risk factors: the
atherosclerosis risk in communities (ARIC) study. Circulation 2011,
123:1501–1508.
29. Jensen PN, Johnson K, Floyd J, Heckbert SR, Carnahan R, Dublin S: A systematic
review of validated methods for identifying atrial fibrillation using
administrative data. Pharmacoepidemiol Drug Saf 2012, 21(Suppl 1):141–147.
30. Hernán MA, Hernández-Díaz S, Robins JM: A structural approach to selection
bias. Epidemiology 2004, 15:615–625.
doi:10.1186/1471-2261-14-69
Cite this article as: Lawani et al.: Birth weight and the risk of atrial
fibrillation in whites and African Americans: the Atherosclerosis Risk In
Communities (ARIC) study. BMC Cardiovascular Disorders 2014 14:69.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Lawani et al. BMC Cardiovascular Disorders 2014, 14:69 Page 8 of 8
http://www.biomedcentral.com/1471-2261/14/69
